DLC Test at Chughtai Lab

The Differential Leukocyte Count (DLC) is a fundamental diagnostic blood test that measures the relative percentage and absolute number of each type of white blood cell (WBC) in your bloodstream. White blood cells, or leukocytes, are the primary defenders of the human immune system, responsible for combating infections, responding to allergens, and identifying abnormal cells. At Chughtai Lab, a premier diagnostic institution in Pakistan with its central reference laboratory in Lahore, the DLC is performed using state-of-the-art automated hematology analyzers alongside manual microscopic evaluations by experienced hematologists. This dual-method approach ensures the highest level of clinical accuracy and diagnostic precision.

The human body utilizes five distinct types of white blood cells, each with a specialized physiological role: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. A DLC test provides a detailed breakdown of these five subpopulations, offering invaluable insights into the functional status of the bone marrow and the active state of the immune system. Clinicians utilize this test to diagnose a wide array of medical conditions, ranging from acute bacterial infections and chronic viral diseases to complex hematological malignancies such as leukemia and myelodysplastic syndromes. By evaluating the specific patterns of elevation or depletion in these cell lines, pathologists at Chughtai Lab can assist physicians in formulating targeted treatment plans, monitoring therapeutic responses, and tracking the progression of chronic illnesses. Whether ordered as part of a routine health screening or as a targeted diagnostic investigation for unexplained symptoms, the DLC remains a cornerstone of modern clinical pathology and patient care.

Clinical Procedure: What to Expect

Patient Preparation

• No Strict Fasting Required: A standard DLC test does not require fasting. You can eat and drink normally before the procedure unless your physician has ordered other concurrent tests that require fasting, such as a fasting blood glucose or lipid profile.
• Hydration: It is highly recommended to drink plenty of water before the test. Proper hydration ensures that your veins are well-filled and easier to access, minimizing discomfort during the blood draw.
• Medication Disclosure: Inform your healthcare provider and the phlebotomist at Chughtai Lab about all medications, vitamins, and herbal supplements you are currently taking. Certain drugs, particularly corticosteroids, chemotherapeutic agents, immunosuppressants, and anti-inflammatory medications, can significantly alter white blood cell counts and distribution.
• Avoid Strenuous Exercise: Refrain from intense physical activity or heavy exercise immediately before the blood draw, as acute physical exertion can temporarily alter the distribution of white blood cells in the peripheral circulation.
• Manage Stress: High levels of emotional or physical stress can trigger a transient physiological increase in certain white blood cells, particularly neutrophils. Try to remain calm and relaxed before the procedure.

During the Procedure

The DLC test involves a standard venipuncture procedure, which is quick, safe, and minimally invasive. When you arrive at a Chughtai Lab collection center or utilize their convenient home sample collection service, a trained phlebotomist will guide you through the process. First, you will be seated comfortably, and the phlebotomist will inspect your arm to locate a suitable vein, typically the median cubital vein in the antecubital fossa (the crook of the elbow). The selected site is thoroughly cleansed with an antiseptic alcohol swab to prevent infection. A sterile elastic band, or tourniquet, is then applied around your upper arm to increase pressure and make the vein more visible and accessible. The phlebotomist will insert a sterile, single-use needle into the vein. You may feel a brief, mild pinch or stinging sensation as the needle enters. Blood is drawn directly into a vacuum collection tube containing ethylenediaminetetraacetic acid (EDTA), an anticoagulant that prevents the blood from clotting and preserves the morphology of the cellular components. Once the required volume of blood is collected, the tourniquet is released, and the needle is gently withdrawn. A sterile cotton ball or gauze pad is immediately applied to the puncture site with mild pressure to stop any minor bleeding, followed by a small adhesive bandage. The entire blood collection process takes less than five minutes. The collected sample is carefully labeled with your unique patient identification details and transported under strict temperature-controlled conditions to the laboratory for analysis. In the laboratory, the sample is processed using automated flow cytometry and digital imaging systems, and if abnormal cells are detected, a manual peripheral blood smear is prepared, stained with Wright-Giemsa stain, and examined under a high-power microscope by a consultant pathologist.

When is a DLC Test Performed?

Investigating Acute or Chronic Infections

Physicians frequently order a DLC test when a patient presents with clinical symptoms suggestive of an ongoing infection. These symptoms may include persistent fever, chills, night sweats, localized pain, swelling, or a productive cough. The immune system responds dynamically to different pathogens by mobilizing specific white blood cells. For instance, an acute bacterial infection typically triggers a rapid increase in neutrophils (neutrophilia) and may cause a left shift, where immature neutrophils are released into the bloodstream. Conversely, viral infections often lead to an increase in lymphocytes (lymphocytosis). By analyzing the specific changes in the leukocyte distribution, the DLC helps clinicians differentiate between bacterial, viral, fungal, and parasitic infections, allowing for the timely administration of appropriate antimicrobial therapies.

Evaluating Bone Marrow and Hematological Disorders

The bone marrow is the primary site of hematopoiesis, where all white blood cells are produced, matured, and released into circulation. A DLC test is an essential screening tool for detecting primary bone marrow disorders and hematological malignancies. Conditions such as acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), myelodysplastic syndromes (MDS), and myelofibrosis disrupt normal hematopoiesis, leading to the production of abnormal, dysfunctional, or immature white blood cells (blasts). Patients experiencing unexplained fatigue, easy bruising, petechiae, frequent nosebleeds, or rapid weight loss are routinely evaluated with a DLC. Pathologists analyze the blood smear to identify abnormal cell morphology, which is crucial for the early detection and classification of these serious hematological conditions.

Monitoring Allergic Reactions and Asthma

Allergic diseases and hypersensitivity reactions are characterized by the activation of specific immune pathways. Eosinophils and basophils play a central role in mediating these responses. A physician may request a DLC test for patients presenting with symptoms of severe allergies, chronic asthma, eczema, or suspected parasitic infections. An elevated eosinophil count (eosinophilia) is a classic indicator of allergic airway inflammation, drug hypersensitivity, or tissue-invasive parasitic diseases. Similarly, basophils release histamine and other inflammatory mediators during allergic events. Monitoring these specific cell lines helps allergists and pulmonologists assess the severity of allergic inflammation, identify potential triggers, and evaluate the efficacy of therapeutic interventions such as corticosteroids or immunotherapies.

Assessing Autoimmune and Inflammatory Conditions

Chronic inflammatory and autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), and vasculitis, cause persistent activation of the immune system. This chronic state of inflammation is often reflected in altered leukocyte counts. A DLC test is utilized to monitor disease activity and flare-ups in patients diagnosed with these conditions. For example, chronic inflammation can lead to persistent neutrophilia or monocytosis. Furthermore, many immunosuppressive medications used to manage autoimmune diseases can suppress bone marrow function, leading to leukopenia or neutropenia. Regular DLC monitoring allows rheumatologists and gastroenterologists to balance treatment efficacy with patient safety by adjusting medication dosages based on cellular counts.

Screening for Immunodeficiency States

Immunodeficiency disorders, whether congenital (primary) or acquired (secondary), compromise the body’s ability to fight off pathogens, leaving patients highly susceptible to recurrent and severe infections. Acquired immunodeficiency can result from viral infections like HIV, chemotherapy, radiation therapy, or post-transplant immunosuppressive regimens. A DLC test is vital for evaluating the immune competence of these vulnerable patients. A significant reduction in lymphocytes (lymphopenia) or neutrophils (neutropenia) indicates a severely compromised immune system. For cancer patients undergoing chemotherapy, regular DLC tests are mandatory to monitor for febrile neutropenia, a life-threatening condition that requires immediate medical intervention and temporary suspension of cancer treatment.

What Does a DLC Test Detect?

A Differential Leukocyte Count (DLC) at Chughtai Lab is capable of detecting a wide range of physiological and pathological conditions by identifying specific quantitative and qualitative abnormalities in white blood cells. The key clinical findings that a DLC can detect include:

• Neutrophilia: An elevated percentage or absolute count of neutrophils, commonly indicating acute bacterial infections, physical trauma, severe burns, acute inflammation, or physiological stress.
• Neutropenia: An abnormally low level of neutrophils, which increases the risk of serious infections and can be caused by chemotherapy, autoimmune disorders, bone marrow failure, or severe viral infections.
• Lymphocytosis: An increased number of lymphocytes, typically associated with acute viral infections (such as infectious mononucleosis, mumps, or hepatitis), chronic lymphocytic leukemia (CLL), or certain bacterial infections like pertussis.
• Lymphopenia: A decreased lymphocyte count, often seen in advanced HIV infection/AIDS, congenital immunodeficiency syndromes, corticosteroid therapy, chemotherapy, or severe systemic stress.
• Monocytosis: An elevation in monocytes, which is frequently associated with chronic infections (such as tuberculosis, bacterial endocarditis, or brucellosis), inflammatory bowel disease, or certain myeloproliferative disorders.
• Monocytopenia: A reduction in monocytes, which can occur in conditions causing generalized bone marrow suppression, hairy cell leukemia, or acute stress states.
• Eosinophilia: An increased eosinophil count, highly characteristic of allergic reactions, asthma, drug hypersensitivities, parasitic infections (especially helminthic infections), and certain dermatological diseases.
• Eosinopenia: A low eosinophil count, which can be caused by elevated corticosteroid levels (Cushing’s syndrome or steroid therapy) and acute bacterial infections.
• Basophilia: An elevated basophil count, which is relatively rare and often associated with myeloproliferative disorders such as chronic myeloid leukemia (CML), polycythemia vera, or severe allergic reactions.
• Basopenia: A decrease in basophils, which is difficult to detect due to their low baseline numbers but can occur during acute allergic reactions, hyperthyroidism, or prolonged steroid therapy.
• Left Shift (Bandemia): The presence of an increased proportion of immature neutrophils (band cells) in the blood, indicating that the bone marrow is rapidly releasing cells to fight an active, severe infection.
• Atypical or Reactive Lymphocytes: Morphologically altered lymphocytes that are larger and have abundant cytoplasm, commonly seen in response to viral infections, particularly Epstein-Barr Virus (EBV) or Cytomegalovirus (CMV).
• Blast Cells: Highly immature white blood cells that should never be present in normal peripheral blood; their detection strongly suggests acute leukemia or other high-grade hematological malignancies.
• Leukocytosis: An overall elevation in the total white blood cell count, reflecting an active immune response, inflammation, or bone marrow overproduction.
• Leukopenia: An overall reduction in the total white blood cell count, indicating compromised immunity or bone marrow suppression.
• Myelocytes and Metamyelocytes: Immature granulocytic precursors that appear in the peripheral blood during severe infections (leukemoid reaction) or myeloproliferative disorders.
• Pelger-Huët Anomaly: A benign genetic or acquired (pseudo-Pelger-Huët) abnormality characterized by hyposegmented neutrophil nuclei, often associated with myelodysplastic syndromes.
• Hypersegmented Neutrophils: Neutrophils with six or more nuclear lobes, which is a classic early indicator of megaloblastic anemia caused by Vitamin B12 or folate deficiency.
• Toxic Granulation: Coarse, dark granules in the cytoplasm of neutrophils, indicating severe infection, inflammation, or response to granulocyte colony-stimulating factor (G-CSF).
• Döhle Bodies: Light blue-gray, oval inclusions in the cytoplasm of neutrophils, commonly observed in patients with infections, burns, or physical trauma.
• Plasmacytoid Lymphocytes: Lymphocytes showing features of plasma cells, indicating active antibody production in response to an antigenic stimulus.
• Leukemoid Reaction: An extreme elevation in white blood cell count (often exceeding 50,000 cells/µL) with a marked left shift, mimicking leukemia but caused by a severe, non-malignant physical stress or infection.
• Bone Marrow Suppression: A generalized decrease in all white blood cell lines, often accompanied by anemia and thrombocytopenia, resulting from chemotherapy, radiation, or aplastic anemia.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its efficiency, technological sophistication, and commitment to rapid diagnostic reporting. For a standard Differential Leukocyte Count (DLC) test, the turnaround time is exceptionally quick. In most cases, routine blood samples processed at Chughtai Lab collection centers are completed, verified by a consultant pathologist, and ready for release within 12 to 24 hours of sample collection. To enhance patient convenience, Chughtai Lab offers multiple seamless methods to access diagnostic reports. Patients receive an automated SMS notification containing a direct link as soon as their report is finalized. Reports can be viewed, downloaded, and printed online through the official Chughtai Lab website portal by entering the unique patient ID and lab number printed on the receipt. Additionally, the Chughtai Lab Mobile App, available for both iOS and Android devices, provides a secure and centralized platform where patients can access their entire diagnostic history, track active tests, and share reports directly with their consulting physicians. For patients who prefer physical copies, reports can be collected directly from any Chughtai Lab diagnostic center or express clinic across Pakistan.

DLC Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Neutrophils	40% to 75% of total WBCs; Absolute: 1,500 to 7,800 cells/µL	Elevated (Neutrophilia) in bacterial infections, acute inflammation, tissue necrosis; Decreased (Neutropenia) in chemotherapy, autoimmune diseases, viral infections.
Lymphocytes	20% to 45% of total WBCs; Absolute: 1,000 to 4,800 cells/µL	Elevated (Lymphocytosis) in viral infections (mononucleosis, pertussis), CLL; Decreased (Lymphopenia) in HIV/AIDS, steroid therapy, severe stress.
Monocytes	2% to 10% of total WBCs; Absolute: 100 to 800 cells/µL	Elevated (Monocytosis) in chronic infections (tuberculosis, endocarditis), inflammatory bowel disease, myelomonocytic leukemia.
Eosinophils	1% to 6% of total WBCs; Absolute: 50 to 500 cells/µL	Elevated (Eosinophilia) in allergic reactions, asthma, parasitic infections, drug hypersensitivity, eosinophilic leukemia.
Basophils	0.5% to 1% of total WBCs; Absolute: 0 to 200 cells/µL	Elevated (Basophilia) in chronic myeloid leukemia (CML), polycythemia vera, ulcerative colitis, severe systemic allergies.
Immature Cells (Blasts / Bands)	Bands: 0% to 5%; Blasts: 0% (Absent)	Presence of Blasts indicates acute leukemia; Elevated Bands (Left Shift) indicates severe acute bacterial infection or bone marrow stimulation.
Cellular Morphology	Normal size, shape, and staining characteristics; no toxic changes	Hypersegmented neutrophils (megaloblastic anemia); Toxic granulation or Döhle bodies (severe infection/inflammation); Atypical lymphocytes (viral infections).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for DLC?

• Experienced Healthcare Professionals: Chughtai Lab employs highly qualified consultant pathologists, hematologists, and certified medical technologists who oversee all diagnostic procedures and report verifications.
• Patient-Focused Care: The organization prioritizes patient comfort, safety, and clear communication, ensuring a seamless diagnostic experience from sample collection to reporting.
• Quality Diagnostic Services: Operating with ISO 15189 certification and participating in international external quality assurance programs, Chughtai Lab guarantees the highest standards of diagnostic accuracy.
• Professional Reporting: Reports are detailed, structured, and easy for both patients and clinicians to interpret, featuring clear reference ranges and pathological notes where necessary.
• Modern Diagnostic Approach: Utilizing state-of-the-art automated hematology analyzers from global leaders in laboratory technology, Chughtai Lab minimizes human error and ensures rapid processing.
• Comfortable Environment: All Chughtai Lab diagnostic centers and express clinics are designed to provide a clean, hygienic, and welcoming environment for patients of all ages.
• Convenient Location: With an extensive network of hundreds of collection centers across Pakistan, finding a Chughtai Lab facility near you is incredibly easy.
• Commitment to Accurate Diagnosis: By combining advanced automation with meticulous manual microscopic review of abnormal samples, Chughtai Lab ensures that every DLC report is clinically reliable.